Maryland 2025 Regular Session

Maryland Senate Bill SB875

Introduced
2/3/25  

Caption

Public Health – Medetomidine and Xylazine Consumer Protection Act

Companion Bills

MD HB1109

Crossfiled Public Health Reform Act

Similar Bills

PA SB865

In miscellaneous provisions, further providing for urine drug screening requirement and providing for medetomidine awareness education.

MD HB1109

Public Health Reform Act

VA HB1103

Medetomidine; manufacturing, selling, giving, distributing, or possessing, penalties.

MD HB417

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

MD SB435

Public Health - Medetomidine and Xylazine Consumer Protection Act

SD HB1169

Classify medetomidine as a Schedule III controlled substance and establish permissible uses.

NY A09001

Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.

NY S09221

Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.